SG Americas Securities’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-53,837
| Closed | -$2.83M | – | 3568 |
|
|
2020
Q3 | $2.83M | Buy |
53,837
+36,869
| +217% | +$1.53M | 0.02% | 567 |
|
|
2020
Q2 | $565K | Sell |
16,968
-8,146
| -32% | -$259K | ﹤0.01% | 1984 |
|
|
2020
Q1 | $683K | Buy |
25,114
+3,003
| +14% | +$83.6K | 0.01% | 1572 |
|
|
2019
Q4 | $436K | Buy |
22,111
+13,869
| +168% | +$222K | ﹤0.01% | 1889 |
|
|
2019
Q3 | $107K | Sell |
8,242
-7,209
| -47% | -$87K | ﹤0.01% | 2701 |
|
|
2019
Q2 | $192K | Sell |
15,451
-14,699
| -49% | -$195K | ﹤0.01% | 2436 |
|
|
2019
Q1 | $438K | Sell |
30,150
-94,764
| -76% | -$1.21M | ﹤0.01% | 1948 |
|
|
2018
Q4 | $1.38M | Buy |
+124,914
| New | +$1.74M | 0.01% | 1114 |
|
|
2018
Q3 | – | Sell |
-5,304
| Closed | -$108K | – | 3593 |
|
|
2018
Q2 | $108K | Buy |
+5,304
| New | +$114K | ﹤0.01% | 3025 |
|
|
2017
Q4 | – | Sell |
-20,988
| Closed | -$388K | – | 3821 |
|
|
2017
Q3 | $388K | Buy |
20,988
+2,477
| +13% | +$41.4K | ﹤0.01% | 2041 |
|
|
2017
Q2 | $313K | Buy |
18,511
+3,410
| +23% | +$51.9K | ﹤0.01% | 2145 |
|
|
2017
Q1 | $202K | Sell |
15,101
-13,543
| -47% | -$212K | ﹤0.01% | 2433 |
|
|
2016
Q4 | $431K | Buy |
+28,644
| New | +$378K | ﹤0.01% | 1794 |
|
|
2016
Q2 | – | Sell |
-10,668
| Closed | -$99K | – | 3144 |
|
|
2016
Q1 | $99K | Buy |
+10,668
| New | +$115K | ﹤0.01% | 2632 |
|
|
2015
Q4 | – | Sell |
-7,088
| Closed | -$116K | – | 3081 |
|
|
2015
Q3 | $116K | Sell |
7,088
-2,090
| -23% | -$42.8K | ﹤0.01% | 1773 |
|
|
2015
Q2 | $209K | Buy |
+9,178
| New | +$183K | ﹤0.01% | 1968 |
|
|
2015
Q1 | – | Sell |
-19,361
| Closed | -$233K | – | 3222 |
|
|
2014
Q4 | $233K | Buy |
+19,361
| New | +$221K | ﹤0.01% | 2298 |
|
|
2014
Q1 | – | Sell |
-5,727
| Closed | -$101K | – | 2880 |
|
|
2013
Q4 | $101K | Sell |
5,727
-3,357
| -37% | -$56.4K | ﹤0.01% | 2406 |
|
|
2013
Q3 | $131K | Buy |
+9,084
| New | +$139K | ﹤0.01% | 2487 |
|
SG Americas Securities's MNTA Position: Q4 2020 in Review
SG Americas Securities sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 53,837 shares — an estimated $2.83M sold.
SG Americas Securities first reported a position in MNTA in Q3 2013 and held it in 19 quarters. The position peaked at $2.83M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- SG Americas Securities reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- SG Americas Securities sold 53,837 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.83M.
- SG Americas Securities first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 19 quarters.
- SG Americas Securities's Momenta Pharmaceuticals, Inc. position peaked at $2.83M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on SG Americas Securities's 13F filing for Q4 2020, filed 4 Feb 2021.